Changes in Serum Type I and III Procollagen Levels in Children with Chronic Renal Failure

Nephron

Volumn 72, Issue 2, 1996, Pages 189-191

  Cinaz, Peyami ^a   Buyan, Necla ^a   Gökçora, Nahide ^a   Elbeg, Şehri ^a   Hasanoğlu, Enver ^a  

^a GAZI UNIVERSITY   (Turkey)

Author keywords

Chronic renal failure; Procollagen I; Procollagen III

Indexed keywords

COLLAGEN TYPE 1; COLLAGEN TYPE 3; PROCOLLAGEN;

ADOLESCENT; ARTICLE; BONE AGE; CHILD; CHRONIC KIDNEY FAILURE; CLINICAL ARTICLE; CONTROLLED STUDY; FEMALE; GROWTH RETARDATION; HUMAN; MALE; OSSIFICATION; PRESCHOOL CHILD; PRIORITY JOURNAL; PUBERTY; RADIOIMMUNOASSAY; SCHOOL CHILD;

ADOLESCENT; BIOLOGICAL MARKERS; BODY HEIGHT; BONE DEVELOPMENT; CHILD; CHILD, PRESCHOOL; FEMALE; GROWTH DISORDERS; HUMANS; KIDNEY FAILURE, CHRONIC; MALE; PROCOLLAGEN; RADIOIMMUNOASSAY; RENAL DIALYSIS;

EID: 0030063095     PISSN: 16608151     EISSN: 22353186     Source Type: Journal    
DOI: 10.1159/000188840     Document Type: Article

References (29)

1. Prockop DJ, Kivirikko KI, Tuedeman L. Guzman NA: The biosynthesis of collagen and its disorders. N Engl J Med 1979;301:13-27.
2. Tiegs RD: Biochemical markers of bone turnover for the clinical assessment of metabolic bone disease. Endocrinol Metab Clin North Am 1990:19:1-18.
3. Graham MF: Propeptides to predict growth velocity. J Pediatr Gastroenterol Nutr 1989:8: 143-145.
4. Schwartz GJ, Brion LP, Spitzer A: The use of plasma creatinine concentration for estimating glomerular filtration rate in infants. Pediatr Clin North Am 1987;34:571-587.
5. Tanner JM. Whitehouse RH. Takaishi M: Standards from birth to maturity for height, weight, height velocity; British children. Arch Dis Child 1966:41:454-471.
6. Greulich WW. Pyle SI: Radiographic Atlas of Skeletal Development of Hand and Wrist, ed 2. Oxford, Blackwell, 1962.
7. Tanner JM: Growth at Adolescence, ed 2. Oxford, Blackwell, 1962.
8. Risteli J, Niemi S, Trivedi P, Mâentausta O, Mowat AP, Risteli L: Rapid equilibrium radioimmunoassay for the amino-terminal propeptide of human type III procollagcn. Clin Chem 1988:34:715-718.
9. Melkko J, Niemi S, Risteli J: Radioimmunoassay of the carboxyterminal propeptide of human typel procollagen. Clin Chem 1990:36: 1328-1332.
10. Mehls O, Blum WF, Schaefer F, Tdnshoff B, Scharer K: Growth failure in renal disease. Baillièrcs Clin Endocrinol Metab 1992:6:665-685.
11. Metzger DL, Kerrigan JR. Krieg RJ Jr, Chan JCM, Rogol DA: Alterations in the neuroendocrine control of growth hormone secretion in the uremic rat. Kidney Int 1993:43:1042-1048.
12. Fine RN. Kahout EC, Brown D. Perlman AJ: Growth after recombinant human growth hormone treatment in children with chronic renal failure: Report of a multicenter randomized double-blind placebo-controlled study. J Pediatr 1994;124:374-382.
13. Schaefer F. Vcldhuis JD. Stanhope R. Jones J. Scharer K: Alterations in growth hormone secretion and clearance in peripubertal boys with chronic renal failure and after renal transplantation. J Clin Endocrinol Mctab 1994;78: 1298-1306.
14. Risteli J. Melkko J. Niemi S. Risteli I.: Use of a marker of a collagen formation in osteoporosis studies. Calcif Tissue Int 1991:49 (suppl):24-25.
15. Carey DE, Goldberg B. Ratzan SK. Rubin KR. Rowe DW: Radioimmunoassay for type I procollagen in growth hormone-deficient children before and during treatment with growth hormone. Pediatr Res 1984;19:8-11.
16. Cinaz P, Hasanoglu E, Gôkçora N. Dogukan S. Demir A: Serum levels of carboxyterminal propeptide of type I procollagen and aminoterminal propeptide of type III procollagen in children with growth retardation. Mater Med Pol 1994;26:55-58.
17. Carey DE. Goldberg B, Ratzan SK. Rubin KR. Rowe DW: Serum immunorcactive procollagen levels in children with growth hormone deficiency and hypothyroidism (abstract). Pediatr Res 1982; 16:135A.
18. Rosenfeld RG. Kemp SF. Hintz RL: Constancy of somatomedin response to growth hormone treatment of hypopituitary dwarfism and lack of correlation with growth rate. J Clin Endocrinol Metab 1981;53:611-617.
19. Saggase G, Bertclloni S. Baroncelli GI, Nero GDI: Serum levels of carboxy terminal propeptide of type I procollagen in healthy children from 1st year of life to adulthood and in metabolic bone diseases. Eur J Pediatr 1992; 151: 764-768.
20. Trivedi P, Risteli J, Risteli L, Hindmarsh C, Brook CGD, Mowat PA: Serum concentrations of the type I and III procollagen propeptides as biochemical markers of growth velocity in healthy infants and children and in children with growth disorders. Pediatr Res 1991;30:276-280.
21. Felice AD, Savazzi AM, Cecchetti LC. Gilioli G, Lusvarght E: Dual energy x-ray absorptiometry (DEXA) total-body, procollagen I (PC-I) and uremic osteodystrophy. 30th Congress of the European Dialysis and Transplant Association, European Renal Association, Glasgow. 1993. p 218.
22. Suzuki I, Muramatsu Y, Akashi S, Yamamoto H, Usui N: Relationship between scrum procollagen type 1 C-terminal peptide and growth velocity in children with chronic renal failure (abstract). Pediatr Nephrol 1993:7:F-27.
23. Hahn EG: Blood analysis for liver fibrosis. J Hepatol 1984;1:67-73.
24. Hahn EG, Schuppan D: Ethanol and fibrogenc-sis in the liver; in Seitz HK, Kommerel! B (eds): Alcohol-Related Diseases in Gastroenterology. Berlin, Springer, 1985, pp 124-153.
25. Rohde V. Vargus L. Hahn EG: Radioimmunoassay for type III procollagen peptide and its application to human liver disease. Eur J Clin Invest 1979:9:451-459.
26. Hahn EG, Schuppan D: Collagen metabolism in liver disease; in Bianchi L, Gerock W, Land-rnann L (eds): Liver in Metabolic Diseases. 35th Falk Svmp. Boston, MTP Press. 1983, pp 309-323.
27. Keller F, Rehbein C, Schwarz A, Fleck M, Hayasaka A, Schuppan D, Oflermann G, Hahn EG: Increased procollagen III production in patients with kidnev disease. Nephron 1988: 50:332-337.
28. Sterzel RB. Lovett DH. Foellmer HG: Mesangial cell hillocks. Nodular foci of exaggerated growth of cells and matrix in prolonged culture. Am J Pathol 1986;125:130-140.
29. Heickendorff L, Frost L. Madsen JK. Pedersen EB: Serum propeptides of type I and III procollagens in renal transplant recipients. Nephron 1994:67:203-208.